StonvexLoading…
StonvexStonvexStonvexCore line items from CDP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $6.04M | $42.07M | $31.20M | $22.72M |
Operating Income | $38.86M | $157.68M | $118.43M | $75.89M |
Net Income | $40.14M | $159.53M | $120.14M | $76.39M |
EPS (Diluted) | $0.34 | $1.34 | $1.01 | $0.64 |
Total Assets | $4.46B | $4.70B | $4.35B | $4.29B |
Total Liabilities | $2.87B | $3.11B | $2.77B | $2.72B |
Cash & Equivalents | $28.58M | $274.99M | $23.69M | $21.29M |
Free Cash Flow OCF − CapEx | $90.17M | $288.87M | $212.59M | $149.67M |
Shares Outstanding | 113.38M | 113.21M | 112.95M | 112.93M |